当前位置:首页 - 行情中心 - 春立医疗(688236) - 财务分析

春立医疗

(688236)

  

流通市值:11.66亿  总市值:56.38亿
流通股本:7929.47万   总股本:3.84亿

春立医疗(688236)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年年度实现净利润1.25亿元,每股收益0.33元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年年度最新股东权益282134.41万元,未分配利润120843.76万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年年度最新总资产346573.50万元,负债64439.08万元。

利润表
报告期2024-12-312024-09-302024-06-302024-03-31
营业总收入805,857,022.19508,283,661.62380,130,570.92221,850,180.79
营业总成本678,243,060.18449,469,327.29304,028,844.65164,450,441.62
营业利润130,714,693.9665,450,654.1782,286,192.4259,325,467.29
利润总额131,599,169.0766,164,634.1683,069,962.5560,164,568.65
净利润124,661,283.561,008,648.4778,960,894.7855,107,063.21
其他综合收益----
综合收益总额124,661,283.561,008,648.4778,960,894.7855,107,063.21
资产负债表
报告期2024-12-312024-09-302024-06-302024-03-31
流动资产合计2,840,481,1262,858,861,848.082,993,697,416.932,899,501,388.96
非流动资产合计625,253,856.98635,956,266.63639,208,735.06643,160,801.73
资产总计3,465,734,982.983,494,818,114.713,632,906,151.993,542,662,190.69
流动负债合计546,745,314.92600,748,118.94720,211,490.68514,691,217.05
非流动负债合计97,645,531.2697,634,331.7493,350,130.5893,682,889.85
负债合计644,390,846.18698,382,450.68813,561,621.26608,374,106.9
归属于母公司股东权益合计2,819,902,283.282,794,809,881.52,817,641,135.162,932,666,469.62
股东权益合计2,821,344,136.82,796,435,664.032,819,344,530.732,934,288,083.79
负债和股东权益合计3,465,734,982.983,494,818,114.713,632,906,151.993,542,662,190.69
现金流量表
报告期2024-12-312024-09-302024-06-302024-03-31
经营活动现金流入小计954,478,736.36739,551,633.47448,447,449.41217,425,731.31
经营活动现金流出小计956,378,287.29756,831,047.22517,505,337.93347,039,070.38
经营活动产生的现金流量净额-1,899,550.93-17,279,413.75-69,057,888.52-129,613,339.07
投资活动现金流入小计2,350,657,632.871,583,044,407.921,421,477,402.73837,229,065.92
投资活动现金流出小计2,294,821,760.261,532,216,273.351,341,842,237.92753,500,759.37
投资活动产生的现金流量净额55,835,872.6150,828,134.5779,635,164.8183,728,306.55
筹资活动现金流入小计----
筹资活动现金流出小计183,139,268.75144,357,900.31554,400-
筹资活动产生的现金流量净额-183,139,268.75-144,357,900.31-554,400-
汇率变动对现金及现金等价物的影响2,207,522.061,677.481,282,812.94-4,213.37
现金及现金等价物净增加额-126,995,425.01-110,807,502.0111,305,689.23-45,889,245.89
期末现金及现金等价物余额1,139,017,650.661,155,205,573.661,277,318,764.91,220,123,829.78
最新报告期:2025-04-01
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
华安证券李婵,谭国超0.520.670.842025-04-01
华泰证券代雯,孔垂岩,王殷杰0.620.750.902025-04-01
国泰君安丁丹,谈嘉程0.530.720.942025-03-30
TOP↑